IHM
IPXL

Iguana Healthcare Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Iguana Healthcare Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-100,000
Closed -$2.64M – 94
2014
Q1 		$2.64M Buy
100,000
+50,000
+100% +$1.25M 1.22% 34
2013
Q4 		$1.19M Buy
+50,000
New +$1.12M 0.68% 46

Other funds holding IPXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Iguana Healthcare Management's IPXL Position: Q2 2017 in Review

Iguana Healthcare Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2017, closing a stake of 100,000 shares — an estimated $1.26M sold.

Iguana Healthcare Management first reported a position in IPXL in Q4 2013 and held it in 12 quarters. The position peaked at $5.74M in Q2 2015. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

  • Iguana Healthcare Management reported no remaining Impax Laboratories, Inc. position as of Q2 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 100,000 Impax Laboratories, Inc. shares in Q2 2017, an estimated $1.26M.
  • Iguana Healthcare Management first reported a position in Impax Laboratories, Inc. in Q4 2013 and held it in 12 quarters.
  • Iguana Healthcare Management's Impax Laboratories, Inc. position peaked at $5.74M in Q2 2015.
  • 172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.